Avalo Change To Inventory from 2010 to 2024

AVTX Stock  USD 10.13  0.48  4.97%   
Avalo Therapeutics Change To Inventory yearly trend continues to be fairly stable with very little volatility. Change To Inventory is likely to outpace its year average in 2024. Change To Inventory is the increase or decrease in the amount of inventory Avalo Therapeutics has over a certain period. View All Fundamentals
 
Change To Inventory  
First Reported
2018-03-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
35 M
 
Covid
Check Avalo Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avalo Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 150.1 K, Interest Expense of 5.6 M or Selling General Administrative of 11.9 M, as well as many indicators such as Price To Sales Ratio of 1.25, Dividend Yield of 0.0 or PTB Ratio of 0.33. Avalo financial statements analysis is a perfect complement when working with Avalo Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Avalo Therapeutics Correlation against competitors.
For more information on how to buy Avalo Stock please use our How to Invest in Avalo Therapeutics guide.

Latest Avalo Therapeutics' Change To Inventory Growth Pattern

Below is the plot of the Change To Inventory of Avalo Therapeutics over the last few years. It is the increase or decrease in the amount of inventory a company has over a certain period. Avalo Therapeutics' Change To Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avalo Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Change To Inventory10 Years Trend
Slightly volatile
   Change To Inventory   
       Timeline  

Avalo Change To Inventory Regression Statistics

Arithmetic Mean(90,469)
Geometric Mean105,614
Coefficient Of Variation(226.78)
Mean Deviation149,061
Median(202,622)
Standard Deviation205,161
Sample Variance42.1B
Range844.1K
R-Value0.52
Mean Square Error33B
R-Squared0.27
Significance0.05
Slope23,928
Total Sum of Squares589.3B

Avalo Change To Inventory History

202421 K
202320 K
202218 K
2021-35 K
202018.2 K
2019532.9 K
2018-311.2 K

About Avalo Therapeutics Financial Statements

Avalo Therapeutics investors use historical fundamental indicators, such as Avalo Therapeutics' Change To Inventory, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Avalo Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change To Inventory20 K21 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Avalo Stock Analysis

When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.